Mondelēz (MDLZ) Q4 2025 earnings review

Pricing Power Masks Deepening Volume Cracks

Mondelēz delivered 5.1% organic growth in Q4, but the composition is alarming: a massive 9.9% pricing hike was required to offset a sharp 4.8% decline in volume/mix. While the company is successfully passing on record cocoa costs, consumer elasticity is snapping—Europe saw volumes plunge 7.4% in response to 15.7% pricing. GAAP earnings collapsed (-61% Net Income) due to derivative mark-to-markets, though Adjusted EPS held up (+4.6% cst FX). The real concern is the FY26 outlook: guiding for 'Flat to 2%' organic growth signals a rapid deceleration from the 4.3% pace of FY25.

🐂 Bull Case

Emerging Markets Resilience

Despite global pressures, Emerging Markets delivered 8.0% organic growth in Q4 (pricing +11.8%), significantly outperforming Developed Markets (+3.4%). AMEA and Latin America remain growth engines.

Margin Recovery Potential

Adjusted Operating Income margin actually expanded +190bps in Q4 (to 11.9%) despite the gross margin pressure, driven by productivity and lower overheads. If cocoa costs stabilize, leverage could return quickly.

🐻 Bear Case

Volume Erosion Accelerating

Volume/Mix declines worsened throughout the year, hitting a low of -4.8% in Q4 (vs -1.5% in Q2). This suggests pricing power is hitting a ceiling and consumers are actively trading down or exiting the category.

North America Stagnation

The critical North American segment remains in contraction (-0.5% organic revenue). With volumes down 3.7% and pricing power evaporating (+3.2% vs double-digits elsewhere), the home market is a drag on results.

⚖️ Verdict: 🔴

Bearish. The quality of growth is low (100% inflation-driven) and volume trends are deteriorating. Guidance for FY26 (0-2% growth) implies the pricing lever is exhausted, leaving the company vulnerable if volumes don't rebound immediately.

Key Themes

CONCERN🔴🔴

European Elasticity Shock

Europe, the company's largest region, is showing signs of breaking point. To combat inflation, MDLZ pushed Q4 pricing up 15.7%, triggering a massive 7.4% volume decline. This trade-off is becoming unsustainable.

CONCERN🔴

Gross Margin Compression

Reported Gross Profit margin collapsed 1,040 bps to 28.2% in Q4. Even on an Adjusted basis, margins fell 100 bps to 30.5%. The 'Cocoa Inflation' narrative is no longer just a risk; it is actively eating into profitability faster than pricing can offset it.

DRIVER

AMEA & Latin America Growth

Emerging markets continue to carry the heavy lifting. AMEA grew +7.5% organic and Latin America +4.4%. Unlike Europe, AMEA maintained decent volume discipline (-1.8% vol vs +9.3% price), showing better brand stickiness in these regions.

THEMENEW🟢

Derivatives Noise Obscures Reality

GAAP results were functionally useless this quarter due to massive mark-to-market impacts from commodity/currency derivatives ($755M hit to Gross Profit). Operating Income fell 41% reported vs rising 22% adjusted. Investors must rely entirely on non-GAAP figures to see underlying performance.

CONCERN

North America Weakness Persists

North America posted -0.5% organic growth, marking a full year of stagnation (FY25 -1.9%). With volume down 3.7% in Q4, the U.S. consumer is clearly pulling back on snacking spend, and MDLZ has limited room left to take price here (+3.2% pricing was the lowest of all regions).

Other KPIs

Adjusted EPS (25Q4)$0.72

Decelerating. While up +4.6% in constant currency, this is significantly below the +10.8% growth seen in 24Q4. The drag from interest expenses and taxes is weighing on the bottom line despite operational cost cuts.

Free Cash Flow (FY25)$3.2 billion

Stable. Down slightly from $3.6B in FY23 and $3.5B in FY24, but remains robust enough to support the $4.9B returned to shareholders (dividends + buybacks) via balance sheet usage.

FY25 Organic Revenue Growth+4.3%

Decelerating. The full year result of 4.3% is a slowdown from the ~14% growth rates seen in prior inflationary years, and the exit rate suggests further slowing ahead.

Guidance

FY26 Organic Net Revenue Growth0% to +2%

Decelerating significantly vs FY25 (+4.3%) and FY24 (+14.4%). Management cites geopolitical and trade uncertainty, but the numbers suggest the end of the inflationary pricing super-cycle.

FY26 Adjusted EPS Growth (Constant FX)0% to +5%

Accelerating slightly vs FY25 (-14.6% decline). However, 'Flat to 5%' is hardly a high-growth ambition and reflects continued cost pressure headwinds (cocoa) that pricing can no longer fully cover.

FY26 Free Cash Flow~$3.0 billion

Stable/Slight Decline. Down slightly from $3.2B in FY25. Indicates working capital or CapEx pressures remain sticky.

Key Questions

North America Turnaround

North America has been negative or flat for four quarters. With pricing power largely tapped out (+3.2%), what is the specific plan to arrest the -3.7% volume decline in FY26?

Cocoa Deflation Strategy

If cocoa prices moderate in 2026, will you retain pricing to rebuild margins, or will competitive pressures force you to lower prices to recover the volume lost in Europe (-7.4%)?

Guidance Conservatism

The FY26 revenue guide of 0-2% is a sharp drop from current trend (5%). Does this assume a recessionary consumer environment, or are you planning to proactively roll back prices?